Isotopen Technologien Munchen Competitors and Similar CompaniesClear all

BioInvent's competitors and similar companies include Inventiva, Pharma Mar and Therapeia.

	BioInvent BioInvent focuses on the discovery and development of antibody-based drugs against cancer.	Inventiva Inventiva is a clinical stage biopharmaceutical company with an expertise in fibrosis, oncology and orphan diseases.	Pharma Mar Pharma Mar is a biopharmaceutical company that engages in the discovery and development of marine-derived anticancer drugs.	Therapeia Therapeia is a company that specializes in the development of diagnostic and therapeutic radiopharmaceuticals for unmet patient needs.
Founding Date	Founding Date 1997	Founding Date 2011	Founding Date 1986	Founding Date 2007
Type	Type Public	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech drug development medical diagnostics oncology pharma	Tags Healthcare biotech clinical research drug development medical diagnostics oncology pharma	Tags Healthcare Manufacturing & Industrial biotech chemicals drug development home care medical diagnostics oncology pharma	Tags Healthcare biotech drug development medical diagnostics oncology pharma therapy
Locations	Locations Lund, SE HQ	Locations Daix, FR HQ	Locations Colmenar Viejo, ES HQ Madrid, ES	Locations Dresden, DE HQ
Employees	Employees 118	Employees 114	Employees 500	Employees N/A
Valuation ($)	Valuation ($) 285.9 m	Valuation ($) 231 m	Valuation ($) 1.4 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) kr226.5m (FY, 2025)	Revenue (est.) €4.5m (FY, 2025)	Revenue (est.) €221.4m (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods €12.3m (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit kr226.6m (FY, 2025)	Gross profit €7.9m (FY, 2025)	Gross profit €232m (FY, 2025)	Gross profit N/A
Net income	Net income (kr332.9m) (FY, 2025)	Net income (€354.1m) (FY, 2025)	Net income €75m (FY, 2025)	Net income N/A